| Erin Voye, AUD | |
|
8675 Valley Creek Rd, Woodbury, MN 55125-2337 | |
| (651) 241-3000 | |
| Not Available |
| Full Name | Erin Voye |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 10 Years |
| Location | 8675 Valley Creek Rd, Woodbury, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962810580 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 9336 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
A newly developed test appears highly accurate in identifying newborns with fragile X syndrome—the most common inherited cause of cognitive impairment—as well as identifying couples who are carriers of the causative gene, reports a study in the March issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
U.S. manufacturers that offer health insurance to employees spend an average of $2.38 per worker per hour on health care, substantially more than the amount spent by foreign competitors, according to a report released on Tuesday by the New America Foundation, the Los Angeles Times reports.
› Verified 9 days ago
| Provider Name | Allina Health System |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
A newly developed test appears highly accurate in identifying newborns with fragile X syndrome—the most common inherited cause of cognitive impairment—as well as identifying couples who are carriers of the causative gene, reports a study in the March issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
U.S. manufacturers that offer health insurance to employees spend an average of $2.38 per worker per hour on health care, substantially more than the amount spent by foreign competitors, according to a report released on Tuesday by the New America Foundation, the Los Angeles Times reports.
› Verified 9 days ago
| Provider Name | Allina Health System |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
A newly developed test appears highly accurate in identifying newborns with fragile X syndrome—the most common inherited cause of cognitive impairment—as well as identifying couples who are carriers of the causative gene, reports a study in the March issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
U.S. manufacturers that offer health insurance to employees spend an average of $2.38 per worker per hour on health care, substantially more than the amount spent by foreign competitors, according to a report released on Tuesday by the New America Foundation, the Los Angeles Times reports.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erin Voye, AUD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Erin Voye, AUD 8675 Valley Creek Rd, Woodbury, MN 55125-2337 Ph: (651) 241-3000 |
News Archive
A newly developed test appears highly accurate in identifying newborns with fragile X syndrome—the most common inherited cause of cognitive impairment—as well as identifying couples who are carriers of the causative gene, reports a study in the March issue of Genetics in Medicine, the official peer-reviewed journal of The American College of Medical Genetics.
GlaxoSmithKline (GSK) had teamed up with leading public-domain data providers European Bioinformatics Institute (EMBL-EBI), the U.S. National Library of Medicine (NLM) and the U.S.-based informatics service provider Collaborative Drug Discovery (CDD) to make freely available key scientific information on more than 13,500 compounds that could ultimately lead to new treatments for malaria.
The availability of established diagnostic kits has enabled researchers to plug-and-play in the design of COVID-19 diagnostics. Such technologies took decades to optimize, but they are now playing an important role in identifying and managing the spread of COVID-19. Recombumin® provides an enhanced solution as part of this toolbox for dealing with this disease
A new optogenetic technology developed at UMass Medical School, called optogenetic immunomodulation, is capable of turning on immune cells to attack melanoma tumors in mice. Using near-infrared light, UMMS researchers have shown they can selectively activate an immune response by controlling the flow of calcium ions into the cell. This breakthrough could lead to less invasive, and more controlled and selective, immunotherapies for cancer treatment.
U.S. manufacturers that offer health insurance to employees spend an average of $2.38 per worker per hour on health care, substantially more than the amount spent by foreign competitors, according to a report released on Tuesday by the New America Foundation, the Los Angeles Times reports.
› Verified 9 days ago
Michaela Nikolai, Audiologist Medicare: Accepting Medicare Assignments Practice Location: 8675 Valley Creek Rd, Woodbury, MN 55125 Phone: 612-241-3000 | |
Erin Foster, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2080 Woodwinds Dr Ste 240, Woodbury, MN 55125 Phone: 651-702-0750 Fax: 651-645-6166 | |
Mary Ellen Slater, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 8675 Valley Creek Rd, Woodbury, MN 55125 Phone: 651-501-3000 Fax: 651-501-3500 | |
Ms. Lisa Scheidt, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 628 Bielenberg Dr, Woodbury, MN 55125 Phone: 612-874-1292 | |
Thomas Asper, Audiologist Medicare: Medicare Enrolled Practice Location: 217 Radio Dr, Woodbury, MN 55125 Phone: 651-702-0750 | |
Mrs. Amanda R Salmon, AUD CCC A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2080 Woodwinds Dr Ste 240, Woodbury, MN 55125 Phone: 651-702-0750 Fax: 651-645-6166 | |
Dr. Carrie A Bell, CCC AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2080 Woodwinds Dr Ste 240, Woodbury, MN 55125 Phone: 651-702-0750 Fax: 651-645-6166 |